From COVID to fibrosis: lessons from single-cell analyses of the human lung
Abstract The increased resolution of single-cell RNA-sequencing technologies has led to major breakthroughs and improved our understanding of the normal and pathologic conditions of multiple tissues and organs. In the study of parenchymal lung disease, single-cell RNA-sequencing has better delineate...
Main Authors: | Aurelien Justet, Amy Y. Zhao, Naftali Kaminski |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40246-022-00393-0 |
Similar Items
-
Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
by: Kristina Krempaska, et al.
Published: (2020-01-01) -
Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis
by: Lorraine Thong, et al.
Published: (2023-02-01) -
Idiopatic pulmonary fibrosis: A new paradigm
by: S N Avdeev
Published: (2017-01-01) -
Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg)
by: Ekaterina Krauss, et al.
Published: (2020-11-01) -
Idiopathic pulmonary fibrosis: the turning point is now!
by: Manuela Funke, et al.
Published: (2015-05-01)